acutally, although SGYP and FURX both deal in constipation, they are also quite different. IBS-C is SGYP's target area and that deals with infrequent bowel movement with pain and bloating......IBS-D is FURX's end of the market and that deals with abdominal pain but not really bloating as the problem is frequent bowel movements that end in diarhea. SGYP's drug Plecanatide has better appearing results than others on the market as far as reducing a side affect of diarhea while achieving the end result of treating the pain and bloating.....both treat constipation and that makes it sound like another copycat sort of deal but really FURX and SGYP are very different.
here's to better tomorrows............
that occurred in...things were dire as they stopped Iso due to the infections and UBS decided, as maybe I would have, that a company going back to ethanol production was doomed. Well, al ot can change in a fairly short while. I'm showing you an old dated article from January of 2013 that marked the beginning of the turnaround....it's an old article and GEVO's progressed far past that point in time. here's the article.
Gevo Falls on ‘Profit Taking’ From Plant Startup Speculation
By Justin Doom Jan 30, 2013 4:33 PM ET
0 Comments Email Print
JunDecMarSep0.002.505.007.5010.0012.50* Price chart for GEVO INC. Click flags for important stories. GEVO:US2.3301/30/13
Gevo Inc. (GEVO), a U.S. biofuel producer backed by French oil company Total SA (FP) and specialty-chemicals maker Lanxess AG (LXS), declined as investors took advantage of speculation the company will resume isobutanol production.
Gevo fell 2.1 percent to $2.33 at the close in New York. Volume was more than seven times the three-month daily average.
Investors are selling today after the Englewood, Colorado- based company jumped 17 percent yesterday, Shawn Severson, a San Francisco-based analyst at JMP Securities LLC, said in a telephone interview.
“It’s profit taking,” said Severson, who rates Gevo the equivalent of buy with a 12-month price target of $6. “If you bought it a couple weeks ago at $1.80 or $1.90, you might be trading around today.”
The gain may be linked to speculation Gevo is preparing to switch back to isobutanol from ethanol at its plant in Luverne, Minnesota, he said.
The company has lost 34 percent of its market value since announcing Sept. 24 that it stopped processing corn into isobutanol, a biofuel that may be blended with gasoline or refined into jet fuel and specialty chemicals, to adjust its manufacturing process.
“The company never gave a time for an expected startup” of isobutanol, Severson said. “My initial thought is that it will be within the first half.”
you can actually use a six month chart and things get really weird.
even moe weird..overlap sucampo (scmp) with the other two. I'm not sure what it means...coincidental? or, is demand whatever the MM says it is and since the MM doesn't have time to be in all sectors at once it trades each sector in some certain fashion...is this truly a free market...maybe we're in the matrix and machines are controlling are perceptions. If so, the machines controlling my sector absolutely suck..heck, I'll give up Morfias in a NY second to change a few things...
that make you go hmmmmmmm.
Makes me curious if we're getting a wee bit of a notification from SGYP as to the timeline is very short till bigger deals happen. Might not be but as Beton says they are cleaning the balance sheet...
messages in a row dedicated to letting the world know what a loser you are. LOL
you POS. LOL
Don't care as I'm not using that one for him. To me, he'll always be known as Jr. - plus takes less time and he know's who's being referred to and that's all that matters.